首頁 > 市場調查報告書 > 工業機械

市場調查報告書

商品編碼

1643903

全球滅菌服務市場 - 2025-2033

Global Sterilization Services Market - 2025-2033

出版日期: 2025年01月27日 | 出版商:

DataM Intelligence | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球滅菌服務市場在2024年達到38億美元，預計2033年將達到65.3億美元，在2025-2033年預測期間複合年成長率為6.4%。

滅菌服務是醫療保健系統的重要組成部分，因為它們確保醫療器械和設備在用於患者之前不含活細菌。這項技術對於預防感染至關重要，特別是在病原體容易傳播的手術環境中。消毒服務包括一系列廣泛的任務，例如對可重複使用的醫療設備進行清潔、消毒和滅菌，所有這些對於病人安全和護理品質都至關重要。

對滅菌服務不斷成長的需求正在推動全球滅菌服務市場的發展。對院內感染的日益擔憂以及全球範圍內進行的外科手術數量的增加正在增加對絕育服務的需求。隨著醫療機構努力提高病患安全並降低感染風險，對有效滅菌技術的需求變得至關重要，這在預測期內推動了市場。

市場動態：

驅動程式和限制

滅菌服務需求增加

對滅菌服務的需求不斷成長預計將成為全球滅菌服務市場成長的重要因素。由於外科手術數量的增加以及對院內感染的擔憂日益增加，對絕育服務的需求不斷增加。

隨著外科手術數量的增加，消毒服務的需求越來越大，以便在手術後消毒手術單元和手術器械以控制感染。例如，根據美國國立衛生研究院的數據，據報道，到 2023 年，每年進行約 40 萬例 CABG 手術，使其成為最受歡迎的主要外科手術。此外，根據美國國立衛生研究院的數據，到2024 年，髖關節和膝關節置換手術是美國最常見的兩種手術，估計有700 萬美國人需要進行完整的髖關節或膝關節置換手術，超過100 萬例置換手術每年都進行。

院內感染的盛行每年影響數百萬患者，導致發病率和醫療支出增加，凸顯了嚴格消毒措施的必要性。醫療保健提供者意識的提高正在推動對可靠滅菌服務的需求，以確保醫療器械和設備在使用前不含有害微生物。因此，隨著手術技術的進步和全球院內感染數量的增加，對滅菌服務的需求增加，全球滅菌服務增加市場熱潮。

用於滅菌服務的化學製劑的有害影響

用於滅菌服務的化學製劑的有害影響等因素預計將阻礙全球滅菌服務市場。環氧乙烷 (EtO) 通常用於對熱敏醫療設備進行消毒，其伴隨的健康風險是醫療保健專業人員和患者的主要擔憂。接觸環氧乙烷會導致許多急性和慢性健康問題，包括呼吸道刺激、頭痛，甚至更嚴重的疾病，如癌症和生殖健康障礙。環氧乙烷被認為是一種已證實的人類致癌物，使其使用變得複雜化，導致審查和監管壓力加大，可能會阻礙市場擴張。

有關此報告的更多詳細資訊 - 索取樣本

Sterilization services are essential components of healthcare systems, as they ensure that medical instruments and devices are free of viable bacteria before being used on patients. This technique is critical for infection prevention, especially in surgical settings where pathogens are easily transmitted. Sterilization services include an extensive list of tasks such as cleaning, disinfecting, and sterilizing reusable medical devices, all of which are critical to patient safety and quality of care.

The increasing demand for sterilization services is driving the global sterilization services market. The rising concerns over hospital-acquired infections and the growing number of surgical procedures performed globally are increasing the demand for sterilization services. As healthcare facilities strive to improve patient safety and reduce infection risks, the need for effective sterilization technologies has grown critical, this drives the market over the forecast period.

Market Dynamics: Drivers & Restraints

Increasing demand for sterilization services

The increasing demand for sterilization services is expected to be a significant factor in the growth of the global sterilization services market. The demand for sterilization services is increasing owing to the increasing number of surgical procedures, and rising concerns over hospital-acquired infections.

As the number of surgical procedures increases, there is an increasing need for sterilization services to sterilize the surgical unit and the surgical instruments after the surgery to control the infections. For instance, according to the National Institute of Health, In 2023, it was reported that around 400,000 CABG operations are conducted each year, making it the most prevalent major surgical procedure. Moreover, according to the National Institute of Health in 2024, hip and knee arthroplasty surgeries are two of the most common procedures performed in the United States, with an estimated 7 million Americans necessitating a complete hip or knee replacement and more than 1 million replacements were performed each year.

The prevalence of hospital-acquired infections, which impact millions of patients each year and contribute to increased morbidity and healthcare expenditures, emphasizes the need for strict sterilization practices. This increased awareness among healthcare providers is driving up demand for dependable sterilization services that ensure medical instruments and devices are free of harmful microbes before use. Thus, as surgical techniques advance and the number of hospital-acquired infections rises globally, the demand for sterilization services increases, and the global sterilization services increase market upsurges.

Harmful effects of chemical agents used for sterilization services

Factors such as the harmful effects of chemical agents used for sterilization services are expected to hamper the global sterilization services market. Ethylene Oxide (EtO) which is commonly used for sterilizing heat-sensitive medical devices, and its accompanying health risks are a major concern for both healthcare professionals and patients. EtO exposure can cause a number of acute and chronic health concerns, including respiratory irritation, headaches, and even more serious illnesses like cancer and reproductive health disorders. The recognition of EtO as a proven human carcinogen complicates its use, resulting in increased scrutiny and regulatory pressures that may hinder market expansion.

For more details on this report - Request for Sample

Segment Analysis

The Global sterilization services Market is segmented based on Method, Type, Mode of Delivery, End-User, And Region.

Gamma Sterilization segment is expected to dominate the global sterilization services market share

Gamma sterilization is anticipated to dominate the global sterilization services market owing to its high efficiency and efficacy in delivering consistent and controlled doses during the sterilizing process and technological advancements. This approach is preferred because it can sterilize a wide range of materials without using heat, making it appropriate for heat-sensitive medical devices. The lack of radioactive sourcing or re-sourcing requirements further helps its popularity by simplifying the logistics required in the sterilizing procedure.

The recent technological advancements in gamma sterilization services are one of the major reasons to make it the most dominating segment. There are recent launches of gamma sterilization services that use advanced working principles for quick and efficient sterilization procedures. For instance, in December 2024, a novel Gamma Irradiation Chamber (GIC) 5000, Cobalt-60, was recently launched at Mumbai University's Department of Biophysics, marking a significant step forward in radiation research. The facility is projected to provide considerable opportunity for researchers in various sectors, including healthcare sterilization, food processing, material science, and radiation chemistry.

Technological advancements and an increasing number of surgical procedures that increase the need for quick and efficient sterilization services increase the demand for gamma sterilization, making this segment the most dominating in the global sterilization services market.

Geographical Analysis

North America is expected to hold a significant position in the global sterilization services market share

North America will likely account for a significant share of the global sterilization services market, owing to the increasing number of surgical procedures, rising concerns over hospital-acquired infections, technological advancements, and recent launches.

The increasing number of surgical procedures in this region drives the market. For instance, in the United States, one in every nine people living in residences reported having at least one surgical treatment by 2023. Individuals aged 65 and older, as well as Medicare beneficiaries, had the greatest rates, with around one in every five reporting having undergone surgery. As the increasing number of surgical procedures the number of hospital-acquired infections rises, which increases the demand for sterilization services in North America.

Moreover, the technological advancements drive the market in this region due to the presence of major players and high healthcare investment towards product research and development. For instance, in March 2024, STERIS has recently developed the Verafit Sterilization Bags and Covers, which are intended to help biopharmaceutical producers comply with the updated GMP Annex 1 criteria. Verafit products are produced with Purefit, a flexible sterilizing wrap that reduces contamination concerns from particles, germs, and chemicals. This design is intended to ensure sterility throughout storage and handling. The technological advancements and the increasing number of surgical procedures increase the demand for sterilization services and drive the market in this region.

Asia Pacific is growing at the fastest pace in the global sterilization services market

The Asia Pacific region is emerging as the fastest-growing market for sterilization services, owing to a combination of demographic trends, an increasing number of surgical procedures, rising concerns over hospital-acquired infections, and technological advancements. The increasing number of surgical procedures in this region drives the market. For instance, according to an article published by the Indian Express, each year, an estimated 30 million surgical procedures are performed in India. Significantly, 85% of surgeries are performed in smaller and mid-sized hospitals, with only 15% taking place in corporate hospitals. An increasing number of surgical procedures increases the number of hospital-acquired infections which increases the demand for sterilization services and makes this region the fastest-growing region.

Competitive Landscape

The major global players in the global sterilization services market are B. Braun Medical Ltd, Stryker Corporation, BGS Beta-Gamma-Service GmbH & Co. KG, E-BEAM Services Inc, Fortive Corporation, Medistri SA, MMM Group, Noxilizer Inc., Sotera Health Company, Steris among others.

Emerging Players

Blue Line Sterilization Services, Microtrol Sterilisation Services Pvt Ltd., and Yashodhan Enterprise among others

Key Developments

In February 2024, Thermo Fisher Scientific has established a new sterile medication facility in Singapore, which will help customers deliver novel medicines and vaccines to the Asia-Pacific market. The new facility features a high-speed, fully automated aseptic fill-finish line for both small and big molecules. This strategic investment in Singapore complements expanded research capabilities at Thermo Fisher Scientific's Customer Experience Center and Bioprocess Design Center, both of which are operational lab facilities that display cutting-edge bioprocessing, life science, and analytical technology.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global sterilization services market report delivers a detailed analysis with 70+ key tables, more than 55 visually impactful figures, and 200 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Method
3.2. Snippet by Type
3.3. Snippet by Mode of Delivery
3.4. Snippet by End-User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
- 4.1.2. Rising Demand for Sterilization Services
- 4.1.3. Restraints
- 4.1.4. Harmful Effects of Chemical Agents Used for the Sterilization Services
- 4.1.5. Opportunity
- 4.1.6. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Method

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
- 6.1.2. Market Attractiveness Index, By Method
6.2. Ethylene Oxide Sterilization*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Gamma Sterilization
6.4. Steam Sterilization
6.5. Electron Beam Radiation Sterilization
6.6. Others

7. By Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 7.1.2. Market Attractiveness Index, By Type
7.2. Contract Sterilization Services*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Sterilization Validation Services

8. By Mode of Delivery

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 8.1.2. Market Attractiveness Index, By Mode of Delivery
8.2. Off-Site Sterilization Services*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. On-Site Sterilization Services

9. By End-User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals and Clinics*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Medical Device Manufacturing Companies
9.4. Pharmaceutical and Biotechnology Companies
9.5. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. U.K.
  - 10.3.7.3. France
  - 10.3.7.4. Spain
  - 10.3.7.5. Italy
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. B. Braun Medical Ltd*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Stryker Corporation
12.3. BGS Beta-Gamma-Service GmbH & Co. KG
12.4. E-BEAM Services Inc
12.5. Fortive Corporation
12.6. Medistri SA
12.7. MMM Group
12.8. Noxilizer Inc.
12.9. Sotera Health Company
12.10. Steris

LIST NOT EXHAUSTIVE